Auro Laboratories Ltd.

Financial

	Auro Laboratories	Vaishali Pharma	Aarey Drugs & Pharma
Operational Metrics
Financials
5 yr Average ROE	15.74 %	7.61 %	5.07 %
5yr average Equity Multiplier	1.68	2.76	2.28
5yr Average Asset Turnover Ratio	1.03	0.89	1.56
5yr Avg Net Profit Margin	9.45 %	3.52 %	1.44 %
Price to Book	3.44	2.2	1.1
P/E	42.68	350.77	26.13
5yr Avg Cash Conversion Cycle	34.28 Days	133.52 Days	77.34 Days
Inventory Days	40.18 Days	6.09 Days	20.31 Days
Days Receivable	87.78 Days	217.95 Days	172.65 Days
Days Payable	76.54 Days	174.07 Days	98.9 Days
5yr Average Interest Coverage Ratio	12.13	2.44	4.14
5yr Avg ROCE	20.0 %	16.76 %	8.93 %
5yr Avg Operating Profit Margin	14.46 %	6.18 %	1.54 %
5 yr average Debt to Equity	0.3	0.6	0.21
5yr CAGR Net Profit	13.98 %	88.82 %	-4.17 %
5yr Average Return on Assets	9.66 %	3.1 %	2.26 %
Shareholdings
Promoter Holding	52.18 %	26.32 %	44.8 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.19 %	-0.42 %	-3.26 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0